ÜRÜN, Y. Et Al. 2017. ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinum based chemotherapy: A systematic review and meta-analysis. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.120 , 120-126.

ÜRÜN, Y., Leow, J. J., Fay, A. P., Albiges, L., Choueiri, T. K., & Bellmunt, J., (2017). ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinum based chemotherapy: A systematic review and meta-analysis. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.120, 120-126.

ÜRÜN, YÜKSEL Et Al. "ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinum based chemotherapy: A systematic review and meta-analysis," CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.120, 120-126, 2017

ÜRÜN, YÜKSEL Et Al. "ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinum based chemotherapy: A systematic review and meta-analysis." CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.120, pp.120-126, 2017

ÜRÜN, Y. Et Al. (2017) . "ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinum based chemotherapy: A systematic review and meta-analysis." CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.120, pp.120-126.

@article{article, author={YÜKSEL ÜRÜN Et Al. }, title={ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinum based chemotherapy: A systematic review and meta-analysis}, journal={CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY}, year=2017, pages={120-126} }